Open-label, phase IV, post-marketing study to evaluate aesthetic improvement in Chinese subjects after treatment with Restylane Kysse.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percentage of Participants Assessed as At Least 1-point Improvement From Baseline on Medicis Lip Fullness Scale (MLFS)
Timeframe: At Week 8
Percentage of Participants Assessed as At Least 1-point Improvement From Baseline on MLFS
Timeframe: At Week 16
Percentage of Participants Assessed as At Least 1-point Improvement From Baseline on MLFS
Timeframe: At Week 24
Percentage of Participants Assessed as At Least 1-point Improvement From Baseline on MLFS
Timeframe: At Week 32
Percentage of Participants Assessed as At Least 1-point Improvement From Baseline on MLFS
Timeframe: At Week 40
Percentage of Participants Assessed as At Least 1-point Improvement From Baseline on MLFS
Timeframe: At Week 48
Change From Baseline on the MLFS by Treatment Area at Week 8 After the Last Injection
Timeframe: 8 weeks after last injection (up to 12 weeks)
Change From Baseline on the MLFS by Treatment Area at Week 16 After the Last Injection
Timeframe: 16 weeks after last injection (up to 20 weeks)
Change From Baseline on the MLFS by Treatment Area at Week 24 After the Last Injection
Timeframe: 24 weeks after last injection (up to 28 weeks)
Change From Baseline on the MLFS by Treatment Area at Week 32 After the Last Injection
Timeframe: 32 weeks after last injection (up to 36 weeks)
Change From Baseline on the MLFS by Treatment Area at Week 40 After the Last Injection
Timeframe: 40 weeks after last injection (up to 44 weeks)
Change From Baseline on the MLFS by Treatment Area at Week 48 After the Last Injection
Timeframe: 48 weeks after last injection (up to 52 weeks)